Leman Micro Devices SA

Leman Micro Devices SA specializes in innovative health technology solutions, focusing on the development of advanced medical devices that enhance cardiovascular monitoring for patients and healthcare providers. Leman Micro Devices SA is a company focused on health technology, headquartered in Lausanne, Switzerland. Founded by Mark-Eric Jones, the company has not undergone any major business pivots or changes in operations. It raised Series A financing from Zuhlke Ventures and StartAngels Network in July 2013, the financial terms of which were not disclosed.

The company has completed 1 deal in total. Leman Micro Devices SA's flagship product is its innovative cuffless blood pressure monitor, which incorporates advanced optical and pressure sensor fusion technology to deliver accurate blood pressure readings without the need for traditional cuffs. This compact device connects to the Leman Micro mobile app, allowing users to monitor their blood pressure, view historical data, and share details with healthcare professionals for better cardiovascular care. The target audience includes individuals with high blood pressure, healthcare providers, and mobile device manufacturers interested in integrating this technology into their devices.

The products are primarily marketed in North America and Europe, addressing a critical health issue affecting approximately 1. 3 billion adults globally. Leman Micro Devices SA generates revenue through partnerships and flexible licensing agreements with mobile device manufacturers, enabling the integration of its patented technology into various consumer electronics. The company also explores B2B arrangements, where manufacturers pay for the rights to use the technology, along with possible direct-to-consumer sales via app subscriptions or health-related services.

Specific pricing structures for these offerings have not been disclosed. Leman Micro Devices SA plans to introduce new products that enhance its current offerings, with specific release dates yet to be announced. The company aims to expand into new markets, particularly targeting regions in North America and Europe by the end of 2024. The funds raised in the Series A financing in July 2013 will support these growth initiatives, allowing the company to enhance its product development and market entry strategies.